These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

96 related articles for article (PubMed ID: 14183277)

  • 1. [CONCENTRATION OF NA-PAS IN THE BLOOD AND ITS TOLERANCE FOLLOWING SINGLE ORAL ADMINISTRATION OF THE WHOLE DAILY DOSE].
    WARESKA W; IZDEBSKA-MAKOSA Z
    Gruzlica (1926); 1964 Apr; 32():305-9. PubMed ID: 14183277
    [No Abstract]   [Full Text] [Related]  

  • 2. [COMPARATIVE STUDIES ON THE TOLERANCE AND ABSORPTION OF SODIUM AND POTASSIUM SALTS OF PAS].
    NIKODEMOWICZ E; OSTROWSKA A
    Gruzlica (1926); 1964 May; 32():459-64. PubMed ID: 14180617
    [No Abstract]   [Full Text] [Related]  

  • 3. [COMPARISON OF THE FREE LEVELS OF BIOLOGICALLY ACTIVE INH IN THE BLOOD SERUM DURING ORAL AND INTRAVENOUS ADMINISTRATION OF INH ALONE AND COMBINED WITH PAS].
    KOLOSOWSKA J; LIBISZOWSKA-STANIUL M
    Gruzlica (1926); 1964 Sep; 32():805-8. PubMed ID: 14249998
    [No Abstract]   [Full Text] [Related]  

  • 4. SINGLE DAILY DOSE REGIMEN OF ISONIAZID AND PAS IN THE TREATMENT OF PULMONARY TUBERCULOSIS.
    WILSON JL; LAMPE WT
    Am Rev Respir Dis; 1964 May; 89():756-9. PubMed ID: 14145228
    [No Abstract]   [Full Text] [Related]  

  • 5. [EXPERIMENTAL STUDY ON THE COMPARISON OF THE EFFECT OF DAILY ADMINISTRATION AND ADMINISTRATION AT INTERVALS, OF ANTITUBERCULAR AGENTS IN VITRO. III. ON DRUG TOLERANCE].
    IKEDA N
    Kyoto Daigaku Kekkaku Kenkyusho Kiyo; 1963 Sep; 12():43-51. PubMed ID: 14113184
    [No Abstract]   [Full Text] [Related]  

  • 6. THE TOLERANCE OF ISONIAZID IN ONE DAILY DOSE.
    BRANDER L
    Acta Tuberc Pneumol Scand; 1964; 43():299-306. PubMed ID: 14166440
    [No Abstract]   [Full Text] [Related]  

  • 7. [STUDY OF THE TOLERANCE TEST OF CURRENT ANTITUBERCULAR AGENTS. II. ON THE VARIOUS FACTORS AFFECTING THE EVALUATION OF THE TOLERANCE TEST].
    YOSHIWARA N
    Kyoto Daigaku Kekkaku Kenkyusho Kiyo; 1963 Sep; 12():52-8. PubMed ID: 14113185
    [No Abstract]   [Full Text] [Related]  

  • 8. [USE IN THE TREATMENT OF PULMONARY TUBERCULOSIS OF A SINGLE DAILY DOSE OF ORAL PAS].
    BONNET PA; VIALLIER J
    Rev Tuberc Pneumol (Paris); 1963 Dec; 27():1209-20. PubMed ID: 14110142
    [No Abstract]   [Full Text] [Related]  

  • 9. LARGE SINGLE DAILY DOSES OF PASOLAC MICROGRANULES, A NEW AMINOSALYL PREPARATION.
    SELROOS O
    Acta Tuberc Pneumol Scand; 1964; 44():186-94. PubMed ID: 14162308
    [No Abstract]   [Full Text] [Related]  

  • 10. [CLINICAL TRIAL OF 3 TYPES OF ORAL TREATMENT OF PULMONARY TUBERCULOSIS. (ISONIAZID+ETHIONAMIDE, ISONIAZID + PAS, ISONIAZID ALONE)].
    LEHIR M; CHICOU J; HETRICK G; MERCIER A; NEEL R; RIST N
    Bull World Health Organ; 1964; 30(5):701-32. PubMed ID: 14196816
    [No Abstract]   [Full Text] [Related]  

  • 11. [PAS LEVEL IN THE BLOOD FOLLOWING VARIOUS MODES OF ADMINISTRATION].
    KOSTIC M; KRAJOVAN R
    Tuberkuloza; 1964; 16():239-46. PubMed ID: 14307922
    [No Abstract]   [Full Text] [Related]  

  • 12. [Comparative concentration of PAS in blood following oral administration of PAS alone and with vitamin C].
    NEDELJKOVIC J; DUGANDZIC S; DUGANDZIC M; TUCAKOVIC M
    Vojnosanit Pregl; 1954; 11(9-10):372-6. PubMed ID: 13226731
    [No Abstract]   [Full Text] [Related]  

  • 13. ISONIAZID, PARA-AMINOSALICYLIC ACID, AND STREPTOMYCIN INTOLERANCE IN 1,744 PATIENTS. AN ANALYSIS OF REACTIONS TO SINGLE DRUGS AND DRUG GROUPS PLUS DATA ON MULTIPLE REACTIONS, TYPE AND TIME OF REACTIONS, AND DESENSITIZATION.
    BERTE SJ; DIMASE JD; CHRISTIANSON CS
    Am Rev Respir Dis; 1964 Oct; 90():598-606. PubMed ID: 14221672
    [No Abstract]   [Full Text] [Related]  

  • 14. [CLINICAL TOLERANCE OF RIFAMYCIN SV ADMINISTERED BY VENOUS PERFUSION. (RESEARCH ON THE USE OF SOLUTIONS CONTAINING OR WITHOUT POLYVINYLPYRROLIDONE AND ON THE ASSOCIATION WITH PARA-AMINOSALYCILIC ACID)].
    NINNI A; GALDIERI R
    Arch Tisiol Mal Appar Respir; 1964 Oct; 19():832-56. PubMed ID: 14265719
    [No Abstract]   [Full Text] [Related]  

  • 15. [PAS concentration in the pulmonary tuberculosis lesion. Part III. The residual condition of PAS-Na after its oral administration].
    HASHIMOTO T
    Kekkaku; 1960 Feb; 35():131-4. PubMed ID: 13851960
    [No Abstract]   [Full Text] [Related]  

  • 16. Effect of sodium para-aminosalicylate on oxygen affinity in normal, sickle and fetal human blood.
    Laasberg LH; Hedley-Whyte J; Laver MB
    J Pharmacol Exp Ther; 1976 Nov; 199(2):441-53. PubMed ID: 10430
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Pharmacokinetics of PAS].
    Khabarov AA; Povaliaeva LI; Novosel'skaia LM
    Farmatsiia; 1977; 26(4):49-50. PubMed ID: 902798
    [No Abstract]   [Full Text] [Related]  

  • 18. [MODIFICATION OF THE TOLERANCE OF PARAAMINOSALYCYLIC ACID WITH THE USE OF THE CALCIUM SALT OF PHOSPHORYLCHOLINE CHLORIDE IN PATIENTS WITH PULMONARY TUBERCULOSIS].
    RODRIGUEZ EV; LOPEZ JA
    Sem Med; 1963 Jul; 123():77-8. PubMed ID: 14086336
    [No Abstract]   [Full Text] [Related]  

  • 19. Determination of p-aminosalicylic acid and its N-acetylated metabolite in human urine by capillary zone electrophoresis as a measure of in vivo N-acetyltransferase 1 activity.
    Cummins CL; O'Neil WM; Soo EC; Lloyd DK; Wainer IW
    J Chromatogr B Biomed Sci Appl; 1997 Sep; 697(1-2):283-8. PubMed ID: 9342682
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [TRIPLE SCHEMA IN THE TREATMENT OF TUBERCULOSIS].
    LAUROC DE
    Rev Paul Med; 1964 Jan; 64():57-62. PubMed ID: 14137921
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.